CPC Subgroup
C12Y 117/01 with NAD+ or NADP+ as acceptor (1.17.1)
Full Title
Oxidoreductases acting on CH or CH2 groups (1.17) > with NAD+ or NADP+ as acceptor (1.17.1)
6 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 117/01001 CDP-4-dehydro-6-deoxyglucose reductase (1.17.1.1)
- C12Y 117/01002 4-Hydroxy-3-methylbut-2-enyl diphosphate reductase (1.17.1.2)
- C12Y 117/01003 Leucoanthocyanidin reductase (1.17.1.3)
- C12Y 117/01004 Xanthine dehydrogenase (1.17.1.4)
- C12Y 117/01005 Nicotinate dehydrogenase (1.17.1.5)
- C12Y 117/01007 3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde dehydrogenase (1.17.1.7)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692